← FDA Drug Approvals (Drugs@FDA)

BEXLUTRY

NDA · New Drug Application · Sponsor: CURIUM · Approved 2026-09-14

Drug application

FDA Application #

NDA218525

Application type

New Drug Application

Brand name

BEXLUTRY

Generic name

Lutetium Lu-177 Dotatate

Active ingredients

LUTETIUM LU-177 DOTATATE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

CURIUM

First approval

2026-09-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown